The Italian Life Science industry is globally recognized as a leading and competitive hub in Europe and beyond, attracting significant investments in pharmaceuticals, medical devices, biotechnology, and healthcare. With over 5,500 companies generating €4.5 billion in revenue in 2022 and an annual growth rate of 10.6%, Italy stands out as a thriving center of innovation. Notably, the country has achieved the fastest growth rate in pharmaceutical exports across Europe over the past decade and ranks first in manufacturing value (CDMO).

Small and medium-sized enterprises (SMEs) form the backbone of Italy’s biotech industry, comprising 80% of its 319 biotech companies. These innovative firms drive progress by investing $1.7 billion annually in R&D and employing more than 3,000 specialized R&D professionals.

To foster collaboration between the Italian and Lithuanian life science sectors and expand Lithuanian life science exports in Europe, LithuaniaBIO, in partnership with the Embassy of the Republic of Lithuania to Italy and the expert team from Bio4Dreams, invites Lithuanian life science companies and academia to the workshop “Roadmap to the Italian Life Science Market.”

This workshop will address key topics such as market entry strategies, building strategic partnerships, and exploring funding opportunities, providing invaluable insights for participants aiming to succeed in the Italian life science market.

About speakers:

• Francesco Maria Senatore, Business Development Director at Bio4Dreams
• Maurizio Mariani, President and CEO of Bridge4Pharma
• Paola Cinquanta, Operations Manager – Regulatory Affairs Senior Associate Partner at PQE Group
• Fabio Bianco, VP Scientific & Corporate Development at Bio4Dreams
• Costanza Conti, Head of Grant Office at Bio4Dreams

Agenda:

You can also find the Agenda here.

Don’t miss this opportunity and register now!